Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ketone doai
Reexamination Certificate
2007-07-06
2009-08-25
Zucker, Paul A (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ketone doai
Reexamination Certificate
active
07579380
ABSTRACT:
The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
REFERENCES:
patent: 6096339 (2000-08-01), Ayer et al.
patent: 6780871 (2004-08-01), Glick et al.
patent: 7241805 (2007-07-01), Oberegger et al.
patent: 2007/0269516 (2007-11-01), Oberegger et al.
patent: 2007/0276047 (2007-11-01), Oberegger et al.
patent: 2007/0281012 (2007-12-01), Oberegger et al.
patent: 2007/0293584 (2007-12-01), Oberegger et al.
U.S. Appl. No. 11/930,644, filed Oct. 31, 2007, Oberegger, et al.
U.S. Appl. No. 11/834,848, filed Aug. 7, 2007, Oberegger, et al.
U.S. Appl. No. 11/766,239, filed Jun. 21, 2007, Oberegger, et al.
U.S. Appl. No. 11/766,213, filed Jun. 21, 2007, Oberegger, et al.
U.S. Appl. No. 11/762,820, filed Jun. 14, 2007, Oberegger, et al.
U.S. Appl. No. 11/762,343, filed Jun. 13, 2007, Oberegger, et al.
U.S. Appl. No. 11/762,840, filed Jun. 14, 2007, Oberegger, et al.
U.S. Appl. No. 11/759,413, filed Jun. 7, 2007, Oberegger, et al.
U.S. Appl. No. 11/755,946, filed May 31, 2007, Oberegger, et al.
U.S. Appl. No. 60/693,906, filed Jun. 27, 2005, Oberegger, et al.
U.S. Appl. No. 11/993,723, filed Dec. 21, 2007, Oberegger, et al.
U.S. Appl. No. 11/768,764, filed Jun. 26, 2007, Nighiem, et al.
U.S. Appl. No. 11/751,768, filed May 22, 2007, Oberegger, et al.
U.S. Appl. No. 11/751,785, filed May 22, 2007, Oberegger, et al.
U.S. Appl. No. 11/762,368, filed Jun. 13, 2007, Oberegger, et al.
U.S. Appl. No. 11/766,251, filed Jun. 21, 2007, Oberegger, et al.
U.S. Appl. No. 11/768,764, filed Jun. 26, 2007, Jackson, et al.
Jackson Graham
Maes Paul
Massardo Pietro
Oberegger Werner
Saleh Mohammad Ashty
Biovail Laboratories International S.R.L.
Oblon & Spivak, McClelland, Maier & Neustadt P.C.
Zucker Paul A
LandOfFree
Modified release formulations of a bupropion salt does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modified release formulations of a bupropion salt, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified release formulations of a bupropion salt will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4088264